140 related articles for article (PubMed ID: 32210190)
1. Synthesis, Anticancer Evaluation and Structure-Activity Analysis of Novel (
Szafrański K; Sławiński J; Tomorowicz Ł; Kawiak A
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210190
[TBL] [Abstract][Full Text] [Related]
2. Novel 2-benzylthio-5-(1,3,4-oxadiazol-2-yl)benzenesulfonamides with anticancer activity: Synthesis, QSAR study, and metabolic stability.
Sławiński J; Szafrański K; Pogorzelska A; Żołnowska B; Kawiak A; Macur K; Belka M; Bączek T
Eur J Med Chem; 2017 May; 132():236-248. PubMed ID: 28364658
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Molecular Structure, Anticancer Activity, and QSAR Study of
Żołnowska B; Sławiński J; Brzozowski Z; Kawiak A; Belka M; Zielińska J; Bączek T; Chojnacki J
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772699
[TBL] [Abstract][Full Text] [Related]
4. Novel 5-Substituted 2-(Aylmethylthio)-4-chloro-N-(5-aryl-1,2,4-triazin-3-yl)benzenesulfonamides: Synthesis, Molecular Structure, Anticancer Activity, Apoptosis-Inducing Activity and Metabolic Stability.
Żołnowska B; Sławiński J; Pogorzelska A; Szafrański K; Kawiak A; Stasiłojć G; Belka M; Ulenberg S; Bączek T; Chojnacki J
Molecules; 2016 Jun; 21(6):. PubMed ID: 27338337
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anticancer activity of some novel trifluoromethylquinolines carrying a biologically active benzenesulfonamide moiety.
Al-Dosari MS; Ghorab MM; Alsaid MS; Nissan YM; Ahmed AB
Eur J Med Chem; 2013 Nov; 69():373-83. PubMed ID: 24077528
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro antitumor activity of novel series 2-benzylthio-4-chlorobenzenesulfonamide derivatives.
Sławiński J; Brzozowski Z
Eur J Med Chem; 2006 Oct; 41(10):1180-9. PubMed ID: 16777268
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, QSAR studies, and metabolic stability of novel 2-alkylthio-4-chloro-N-(5-oxo-4,5-dihydro-1,2,4-triazin-3-yl)benzenesulfonamide derivatives as potential anticancer and apoptosis-inducing agents.
Żołnowska B; Sławiński J; Pogorzelska A; Szafrański K; Kawiak A; Stasiłojć G; Belka M; Zielińska J; Bączek T
Chem Biol Drug Des; 2017 Sep; 90(3):380-396. PubMed ID: 28122174
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro anticancer screening of some novel 4-[2-amino-3-cyano-4-substituted-5,6,7,8-tetrahydroquinolin-1-(4H)-yl]benzenesulfonamides.
Al-Said MS; Ghorab MM; Al-Qasoumi SI; El-Hossary EM; Noaman E
Eur J Med Chem; 2010 Jul; 45(7):3011-8. PubMed ID: 20413187
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, Molecular Structure, Metabolic Stability and QSAR Studies of a Novel Series of Anticancer N-Acylbenzenesulfonamides.
Żołnowska B; Sławiński J; Belka M; Bączek T; Kawiak A; Chojnacki J; Pogorzelska A; Szafrański K
Molecules; 2015 Oct; 20(10):19101-29. PubMed ID: 26506328
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, molecular structure, and in vitro antitumor activity of new 4-chloro-2-mercaptobenzenesulfonamide derivatives.
Sławiński J; Gdaniec M
Eur J Med Chem; 2005 Apr; 40(4):377-89. PubMed ID: 15804537
[TBL] [Abstract][Full Text] [Related]
11. Novel 4/3-((4-oxo-5-(2-oxoindolin-3-ylidene)thiazolidin-2-ylidene)amino) benzenesulfonamides: Synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies.
Eldehna WM; Abo-Ashour MF; Nocentini A; Gratteri P; Eissa IH; Fares M; Ismael OE; Ghabbour HA; Elaasser MM; Abdel-Aziz HA; Supuran CT
Eur J Med Chem; 2017 Oct; 139():250-262. PubMed ID: 28802125
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, anticancer and radiosensitizing evaluation of some novel sulfonamide derivatives.
Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; Zahran SS
Eur J Med Chem; 2015 Mar; 92():682-92. PubMed ID: 25618015
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationship of 4-azaheterocycle benzenesulfonamide derivatives as new microtubule-targeting agents.
Yang J; Zhou S; Ji L; Zhang C; Yu S; Li Z; Meng X
Bioorg Med Chem Lett; 2014 Nov; 24(21):5055-8. PubMed ID: 25278233
[TBL] [Abstract][Full Text] [Related]
14. Novel Sulfonamide Derivatives Carrying a Biologically Active 3,4-Dimethoxyphenyl Moiety as VEGFR-2 Inhibitors.
Ghorab MM; Alsaid MS; Nissan YM; Ashour AE; Al-Mishari AA; Kumar A; Ahmed SF
Chem Pharm Bull (Tokyo); 2016; 64(12):1747-1754. PubMed ID: 27904083
[TBL] [Abstract][Full Text] [Related]
15. Novel 1,4-naphthoquinone-based sulfonamides: Synthesis, QSAR, anticancer and antimalarial studies.
Pingaew R; Prachayasittikul V; Worachartcheewan A; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2015 Oct; 103():446-59. PubMed ID: 26397393
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors.
Chen Z; Wang ZC; Yan XQ; Wang PF; Lu XY; Chen LW; Zhu HL; Zhang HW
Bioorg Med Chem Lett; 2015 May; 25(9):1947-51. PubMed ID: 25866240
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anti-breast cancer evaluation of novel N-(guanidinyl)benzenesulfonamides.
Ghorab MM; El-Gazzar MG; Alsaid MS
Int J Mol Sci; 2014 Apr; 15(4):5582-95. PubMed ID: 24694543
[TBL] [Abstract][Full Text] [Related]
18. New Quinoline Based Sulfonamide Derivatives: Cytotoxic and Apoptotic Activity Evaluation Against Pancreatic Cancer Cells.
Yurttaş L; Çiftçi GA
Anticancer Agents Med Chem; 2018; 18(8):1122-1130. PubMed ID: 29521252
[TBL] [Abstract][Full Text] [Related]
19. Novel Thiourea Derivatives Bearing Sulfonamide Moiety as Anticancer Agents Through COX-2 Inhibition.
Ghorab MM; El-Gaby MSA; Alsaid MS; Elshaier YAMM; Soliman AM; El-Senduny FF; Badria FA; Sherif AYA
Anticancer Agents Med Chem; 2017; 17(10):1411-1425. PubMed ID: 28356021
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel 2-arylvinyl-substituted naphtho[2,3-d]imidazolium halide derivatives as potent antitumor agents.
Wei Q; Li J; Tang F; Yin Y; Zhao Y; Yao Q
Eur J Med Chem; 2018 Jan; 144():504-516. PubMed ID: 29288947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
